---
title: A blueprint for pursuing therapeutic interventions and early phase clinical
  trials in clonal haematopoiesis
date: '2024-12-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39653653/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20241210175334&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: The age-associated mutational state of clonal haematopoiesis (CH) is
  linked to multiple adverse health outcomes. As higher risk CH can lead to progressive
  neoplastic or vascular disease, there is interest in developing clinical trials
  to mitigate risk associated with CH. Given the high prevalence of CH, data from
  clinical trials could have broad public health implications for screening and therapy.
  Thoughtful consideration is needed to design trials that are both clinically relevant
  and ...
disable_comments: true
---
The age-associated mutational state of clonal haematopoiesis (CH) is linked to multiple adverse health outcomes. As higher risk CH can lead to progressive neoplastic or vascular disease, there is interest in developing clinical trials to mitigate risk associated with CH. Given the high prevalence of CH, data from clinical trials could have broad public health implications for screening and therapy. Thoughtful consideration is needed to design trials that are both clinically relevant and ...